The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
A Peptide Mimicking VGLL4 Function Acts as a YAP Antagonist Therapy against Gastric Cancer
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Zhao, B., Wei, X., Li, W., Udan, R. S., Yang, Q., Kim, J., Xie, J., Ikenoue, T., Yu, J., Li, L., et al. (2007) · Genes & Development · doi:10.1101/gad.1602907 · Cited by 3,092
TEAD mediates YAP-dependent gene induction and growth control
Zhao, B., Ye, X., Yu, J., Li, L., Li, W., Li, S., Yu, J., Lin, J. D., Wang, C.-Y., Chinnaiyan, A. M., et al. (2008) · Genes & Development · doi:10.1101/gad.1664408 · Cited by 2,498
The Hippo Signaling Pathway in Development and Cancer
Pan, D. (2010) · Developmental Cell · doi:10.1016/j.devcel.2010.09.011 · Cited by 2,269
Huang, J., Wu, S., Barrera, J., Matthews, K., & Pan, D. (2005) · Cell · doi:10.1016/j.cell.2005.06.007 · Cited by 1,863
Liu-Chittenden, Y., Huang, B., Shim, J. S., Chen, Q., Lee, S.-J., Anders, R. A., Liu, J. O., & Pan, D. (2012) · Genes & Development · doi:10.1101/gad.192856.112 · Cited by 1,452
The Hippo–YAP pathway in organ size control and tumorigenesis: an updated version
Zhao, B., Li, L., Lei, Q., & Guan, K.-L. (2010) · Genes & Development · doi:10.1101/gad.1909210 · Cited by 1,144
Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach
Zender, L., Spector, M. S., Xue, W., Flemming, P., Cordon-Cardo, C., Silke, J., Fan, S.-T., Luk, J. M., Wigler, M., Hannon, G. J., et al. (2006) · Cell · doi:10.1016/j.cell.2006.05.030 · Cited by 1,065
Hippo signaling: growth control and beyond
Halder, G., & Johnson, R. L. (2011) · Development · doi:10.1242/dev.045500 · Cited by 1,060
Zhou, D., Conrad, C., Xia, F., Park, J.-S., Payer, B., Yin, Y., Lauwers, G. Y., Thasler, W., Lee, J. T., Avruch, J., et al. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.09.026 · Cited by 913
Hamaratoglu, F., Willecke, M., Kango-Singh, M., Nolo, R., Hyun, E., Tao, C., Jafar-Nejad, H., & Halder, G. (2006) · Nature Cell Biology · doi:10.1038/ncb1339 · Cited by 767
Wu, S., Liu, Y., Zheng, Y., Dong, J., & Pan, D. (2008) · Developmental Cell · doi:10.1016/j.devcel.2008.01.007 · Cited by 640 · cited 2×
“…downstream transcriptional coactivator Yorkie (Yki; YAP/TAZ in mammals), thus preventing its interaction with and therefore transactivation of the DNAbinding transcriptional factor Scalloped (Sd; TEADs/TEF in mammals) (Goulev et al., 2008; Wu et al., 2008; Zhang et al., 2008; Zhao et al., 2008).”
BackgroundThe TEAD/TEF family of transcription factor Scalloped mediates Hippo signaling in organ size control
Zhang, L., Ren, F., Zhang, Q., Chen, Y., Wang, B., & Jiang, J. (2008) · Developmental Cell · doi:10.1016/j.devcel.2008.01.006 · Cited by 630
Self-citationThe Salvador–Warts–Hippo pathway — an emerging tumour-suppressor network
Harvey, K., & Tapon, N. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2070 · Cited by 628
The Hippo Pathway Regulates Wnt/β-Catenin Signaling
Varelas, X., Miller, B. W., Sopko, R., Song, S., Gregorieff, A., Fellouse, F. A., Sakuma, R., Pawson, T., Hunziker, W., McNeill, H., et al. (2010) · Developmental Cell · doi:10.1016/j.devcel.2010.03.007 · Cited by 569
Expression of Yes-associated protein in common solid tumors
Steinhardt, A. A., Gayyed, M. F., Klein, A. P., Dong, J., Maitra, A., Pan, D., Montgomery, E. A., & Anders, R. A. (2008) · Human Pathology · doi:10.1016/j.humpath.2008.04.012 · Cited by 552
Restriction of intestinal stem cell expansion and the regenerative response by YAP
Barry, E. R., Morikawa, T., Butler, B. L., Shrestha, K., de la Rosa, R., Yan, K. S., Fuchs, C. S., Magness, S. T., Smits, R., Ogino, S., et al. (2013) · Nature · doi:10.1038/nature11693 · Cited by 543
Role of TAZ as Mediator of Wnt Signaling
Azzolin, L., Zanconato, F., Bresolin, S., Forcato, M., Basso, G., Bicciato, S., Cordenonsi, M., & Piccolo, S. (2012) · Cell · doi:10.1016/j.cell.2012.11.027 · Cited by 493
The Hippo signaling pathway restricts the oncogenic potential of an intestinal regeneration program
Cai, J., Zhang, N., Zheng, Y., de Wilde, R. F., Maitra, A., & Pan, D. (2010) · Genes & Development · doi:10.1101/gad.1978810 · Cited by 492
Goulev, Y., Fauny, J. D., Gonzalez-Marti, B., Flagiello, D., Silber, J., & Zider, A. (2008) · Current Biology · doi:10.1016/j.cub.2008.02.034 · Cited by 452
Zeng, Q., & Hong, W. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.02.011 · Cited by 435
Kibra Is a Regulator of the Salvador/Warts/Hippo Signaling Network
Genevet, A., Wehr, M. C., Brain, R., Thompson, B. J., & Tapon, N. (2010) · Developmental Cell · doi:10.1016/j.devcel.2009.12.011 · Cited by 402
Fernandez-L, A., Northcott, P. A., Dalton, J., Fraga, C., Ellison, D., Angers, S., Taylor, M. D., & Kenney, A. M. (2009) · Genes & Development · doi:10.1101/gad.1824509 · Cited by 377
The Hippo pathway transcriptional co-activator, YAP, is an ovarian cancer oncogene
Zhang, X., George, J., Deb, S., Degoutin, J. L., Takano, E. A., Fox, S. B., AOCS Study group, Bowtell, D. D. L., & Harvey, K. F. (2011) · Oncogene · doi:10.1038/onc.2011.8 · Cited by 309
Zhang, W., Gao, Y., Li, P., Shi, Z., Guo, T., Li, F., Han, X., Feng, Y., Zheng, C., Wang, Z., et al. (2014) · Cell Research · doi:10.1038/cr.2014.10 · Cited by 296
Self-citationNeto-Silva, R. M., de Beco, S., & Johnston, L. A. (2010) · Developmental Cell · doi:10.1016/j.devcel.2010.09.009 · Cited by 287
Koontz, L. M., Liu-Chittenden, Y., Yin, F., Zheng, Y., Yu, J., Huang, B., Chen, Q., Wu, S., & Pan, D. (2013) · Developmental Cell · doi:10.1016/j.devcel.2013.04.021 · Cited by 283
Konsavage, W. M., Kyler, S. L., Rennoll, S. A., Jin, G., & Yochum, G. S. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.327767 · Cited by 279
Houghton, J., & Wang, T. C. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.03.037 · Cited by 276
Sleeping Beauty mutagenesis reveals cooperating mutations and pathways in pancreatic adenocarcinoma
Mann, K. M., Ward, J. M., Yew, C. C. K., Kovochich, A., Dawson, D. W., Black, M. A., Brett, B. T., Sheetz, T. E., Dupuy, A. J., Initiative, A. P. C. G., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1202490109 · Cited by 213
Maeda, T., Chapman, D. L., & Stewart, A. F. R. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206858200 · Cited by 174
Structural and Functional Similarity between the Vgll1-TEAD and the YAP-TEAD Complexes
Pobbati, A. V., Chan, S. W., Lee, I., Song, H., & Hong, W. (2012) · Structure · doi:10.1016/j.str.2012.04.004 · Cited by 169
The hippo pathway in biological control and cancer development
Chan, S. W., Lim, C. J., Chen, L., Chong, Y. F., Huang, C., Song, H., & Hong, W. (2011) · Journal of Cellular Physiology · doi:10.1002/jcp.22435 · Cited by 167
TRIB2 Acts Downstream of Wnt/TCF in Liver Cancer Cells to Regulate YAP and C/EBPα Function
Wang, J., Park, J.-S., Wei, Y., Rajurkar, M., Cotton, J. L., Fan, Q., Lewis, B. C., Ji, H., & Mao, J. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.05.013 · Cited by 159
Self-citationThe Evolution of Antibodies into Versatile Tumor-Targeting Agents
Lin, M. Z., Teitell, M. A., & Schiller, G. J. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.129.11.1 · Cited by 137
YAP oncogene overexpression supercharges colon cancer proliferation
Avruch, J., Zhou, D., & Bardeesy, N. M. (2012) · Cell Cycle · doi:10.4161/cc.11.6.19453 · Cited by 136
Vaudin, P., Delanoue, R., Davidson, I., Silber, J., & Zider1, A. (1999) · Development · doi:10.1242/dev.126.21.4807 · Cited by 133
Structures of YAP protein domains reveal promising targets for development of new cancer drugs
Sudol, M., Shields, D. C., & Farooq, A. (2012) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2012.05.002 · Cited by 124
A novel partner of Scalloped regulates Hippo signaling via antagonizing Scalloped-Yorkie activity
Guo, T., Lu, Y., Li, P., Yin, M.-X., Lv, D., Zhang, W., Wang, H., Zhou, Z., Ji, H., Zhao, Y., et al. (2013) · Cell Research · doi:10.1038/cr.2013.120 · Cited by 122
Self-citationChen, H., Mullett, S. J., & Stewart, A. F. R. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m400154200 · Cited by 116
Effects of the Hippo Signaling Pathway in Human Gastric Cancer
Zhou, G., Li, X., Zhang, Q., Zhao, K., Zhang, C., Xue, C.-H., YANG, K. Y., & Tian, Z. (2013) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2013.14.9.5199 · Cited by 104
Lin, M.-T., Zuon, C.-Y., Chang, C.-C., Chen, S., Chen, C., Lin, B., Wang, M., Jeng, Y., Chang, K., Lee, P., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2639 · Cited by 99
Opposite Feedbacks in the Hippo Pathway for Growth Control and Neural Fate
Jukam, D., Xie, B., Rister, J., Terrell, D., Charlton-Perkins, M. A., Pistillo, D., Gebelein, B. A., Desplan, C., & Cook, T. A. (2013) · Science · doi:10.1126/science.1238016 · Cited by 92
Da, C.-L. (2009) · World Journal of Gastroenterology · doi:10.3748/wjg.15.4055 · Cited by 72
Jiang, C., Lv, L., Liu, F., Wang, Z.-N., Liu, F., Li, Y., Wang, C.-Y., Zhang, H., Sun, Z., & Xu, H. (2011) · Molecular Cancer · doi:10.1186/1476-4598-10-122 · Cited by 71
VITO-1 is an essential cofactor of TEF1-dependent muscle-specific gene regulation
Günther, S., Mielcarek, M., Krüger, M., & Braun, T. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh248 · Cited by 70
Vestigial-like 3 is an inhibitor of adipocyte differentiation
Halperin, D. S., Pan, C., Lusis, A. J., & Tontonoz, P. (2012) · Journal of Lipid Research · doi:10.1194/jlr.m032755 · Cited by 69
Connective tissue growth factor in tumor pathogenesis
Jacobson, A., & Cunningham, J. L. (2012) · Fibrogenesis & Tissue Repair · doi:10.1186/1755-1536-5-s1-s8 · Cited by 63
Gene expression profiling in a mouse model of Helicobacter‐induced gastric cancer
Takaishi, S., & Wang, T. C. (2007) · Cancer Science · doi:10.1111/j.1349-7006.2007.00392.x · Cited by 61
Quit your YAPing: a new target for cancer therapy: Figure 1.Preprint
Stanger, B. Z. (2012) · Genes & Development · doi:10.1101/gad.196501.112 · Cited by 57
Cui, Z.-L., Han, F.-F., Peng, X.-H., Chen, X., Luan, C.-Y., Han, R.-C., Xu, W.-G., & Guo, X.-J. (2012) · International Journal of Immunopathology and Pharmacology · doi:10.1177/039463201202500416 · Cited by 56
Faucheux, C., Naye, F., Tréguer, K., Fédou, S., Thiébaud, P., & Thézé, N. (2010) · The International Journal of Developmental Biology · doi:10.1387/ijdb.103080cf · Cited by 50
Hippo pathway in intestinal homeostasis and tumorigenesis
Chen, L., Qin, F., Deng, X., Avruch, J., & Zhou, D. (2012) · Protein & Cell · doi:10.1007/s13238-012-2913-9 · Cited by 42
Hergovich, A. (2012) · Breast Cancer Research · doi:10.1186/bcr3349 · Cited by 37
Zhao, Z., Li, L., Wang, H., & Wang, Y. (2011) · Journal of Surgical Oncology · doi:10.1002/jso.21984 · Cited by 35
Self-citationMaeta, N., Osaki, M., Shomori, K., Inaba, A., Kidani, K., Ikeguchi, M., & Ito, H. (2007) · Oncology · doi:10.1159/000121000 · Cited by 27
Cited by
Hippo pathway in organ size control, tissue homeostasis, and cancer
Yu, F.-X., Zhao, B., & Guan, K.-L. (2015) · Cell · doi:10.1016/j.cell.2015.10.044 · Cited by 2,206
YAP/TAZ at the Roots of Cancer
Zanconato, F., Cordenonsi, M., & Piccolo, S. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.05.005 · Cited by 1,970
The Biology of YAP/TAZ: Hippo Signaling and Beyond
Piccolo, S., Dupont, S., & Cordenonsi, M. (2014) · Physiological Reviews · doi:10.1152/physrev.00005.2014 · Cited by 1,802
Mechanisms of Hippo pathway regulation
Meng, Z., Moroishi, T., & Guan, K.-L. (2016) · Genes & Development · doi:10.1101/gad.274027.115 · Cited by 1,667
The Hippo Pathway: Biology and Pathophysiology
Ma, S., Meng, Z., Chen, R., & Guan, K.-L. (2019) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-013118-111829 · Cited by 1,387
Metadata
- Authors
- Jiao, S., Wang, H., Shi, Z., Dong, A., Zhang, W., Song, X., He, F., Wang, Y., Zhang, Z., Wang, W., Wang, X., Guo, T., Li, P., Zhao, Y., Ji, H., Zhang, L., & Zhou, Z.
- Venue
- Cancer Cell
- Publisher
- Elsevier BV
- Published
- 2014-02
- Volume
- 25
- Issue
- 2
- Pages
- 166-180
- ISSN
- 1535-6108 (ISSN-L)
- OpenAlex
- W2078273305
- Cited by
- 602
- References
- 55
- FWCI
- 21.77
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.